Mostrar el registro sencillo del ítem
Brucella canis induces canine CD4 + T cells multi-cytokine Th1/Th17 production via dendritic cell activation
dc.contributor.author | Pujol M. | |
dc.contributor.author | Borie C. | |
dc.contributor.author | Montoya M. | |
dc.contributor.author | Ferreira A. | |
dc.contributor.author | Vernal R. | |
dc.date.accessioned | 2020-09-02T22:25:59Z | |
dc.date.available | 2020-09-02T22:25:59Z | |
dc.date.issued | 2019 | |
dc.identifier | 10.1016/j.cimid.2018.11.017 | |
dc.identifier.citation | 62, , 68-75 | |
dc.identifier.issn | 01479571 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12728/5856 | |
dc.description | Brucella canis is a small intracellular Gram-negative bacterium that frequently leads to chronic infections highly resistant to antibiotic therapy in dogs. Also, it causes mild human brucellosis compared to other zoonotic Brucella spp. Herein we characterize the cellular immune response elicited by B. canis by analysing human and canine CD4 + T cells after stimulation with autologous monocyte-derived dendritic cells (MoDCs). Human and canine B. canis-primed MoDCs stimulated autologous CD4 + T cells; however, a Th1 response was triggered by human MoDCs, whereas canine MoDCs induced Th1/Th17 responses, with increased CD4 + T cells producing IFN-γ and IL-17A simultaneously. Each pattern of cellular response may contribute to host susceptibility, helping to understand the differences in B. canis virulence between these two hosts. In addition, other aspects of canine immunology are unveiled by highlighting the participation of IL-17A-producing canine MoDCs and CD4 + T cells producing IFN-γ and IL-17A. © 2018 Elsevier Ltd | |
dc.language.iso | en | |
dc.publisher | Elsevier Ltd | |
dc.subject | Brucella canis | |
dc.subject | CD4 + T cells | |
dc.subject | Cytokines | |
dc.subject | Dendritic cells | |
dc.subject | Host susceptibility | |
dc.subject | gamma interferon | |
dc.subject | interleukin 12 | |
dc.subject | interleukin 17 | |
dc.subject | tumor necrosis factor | |
dc.subject | biological marker | |
dc.subject | cytokine | |
dc.subject | animal cell | |
dc.subject | Article | |
dc.subject | bacterial strain | |
dc.subject | bacterial virulence | |
dc.subject | Brucella canis | |
dc.subject | CD4+ T lymphocyte | |
dc.subject | cell activation | |
dc.subject | cell isolation | |
dc.subject | cell proliferation | |
dc.subject | controlled study | |
dc.subject | cytokine production | |
dc.subject | dendritic cell | |
dc.subject | dog breed | |
dc.subject | female | |
dc.subject | host susceptibility | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | immune response | |
dc.subject | male | |
dc.subject | monocyte | |
dc.subject | nonhuman | |
dc.subject | protein expression | |
dc.subject | Th1 cell | |
dc.subject | Th17 cell | |
dc.subject | animal | |
dc.subject | biosynthesis | |
dc.subject | Brucella canis | |
dc.subject | brucellosis | |
dc.subject | CD4+ T lymphocyte | |
dc.subject | cell communication | |
dc.subject | dendritic cell | |
dc.subject | dog | |
dc.subject | dog disease | |
dc.subject | immunology | |
dc.subject | immunophenotyping | |
dc.subject | lymphocyte activation | |
dc.subject | metabolism | |
dc.subject | microbiology | |
dc.subject | physiology | |
dc.subject | Th1 cell | |
dc.subject | Th17 cell | |
dc.subject | veterinary medicine | |
dc.subject | Animals | |
dc.subject | Biomarkers | |
dc.subject | Brucella canis | |
dc.subject | Brucellosis | |
dc.subject | CD4-Positive T-Lymphocytes | |
dc.subject | Cell Communication | |
dc.subject | Cytokines | |
dc.subject | Dendritic Cells | |
dc.subject | Dog Diseases | |
dc.subject | Dogs | |
dc.subject | Humans | |
dc.subject | Immunophenotyping | |
dc.subject | Lymphocyte Activation | |
dc.subject | Th1 Cells | |
dc.subject | Th17 Cells | |
dc.title | Brucella canis induces canine CD4 + T cells multi-cytokine Th1/Th17 production via dendritic cell activation | |
dc.type | Article |